( Laboratory Corporation of America Holdings)

	LH latest price $84.3700 (-0.08%) ($84.2500 - $84.9500) on Mon. Nov. 12, 2012.
	Trend Analysis and Forecast
Average Daily Percentage Swing	0.87% (three month average)
RSI	34
Latest Price	$84.3700(-0.08%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	LH declines -0.5% a day on average for past five trading days.
Weekly Trend	LH declines -0.6% a week on average for past two weeks.
Market Behavior	Normal for large cap. Normal for small cap.
Correlated ETFs	Broad market will support LH advance at 0% a week (0% probability)   SPY(58%)    IWM(55%)    XLY(50%)    PEJ(49%)    QQQ(49%)
Factors Impacting LH price	LH will decline at least -0.435% in a week (0% probabilities).   TLT(-10%)    IGOV(-6%)    SHY(0%)    GLD(4%)    TIP(5%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.435% (StdDev 0.87%)
Hourly BBV	0 ()
Intraday Trend	-0.4%

1 - 5 Day Possible Target	$80.46(-4.63%)
Resistance Level	$86.78
5 Day Moving Average	$84.9(-0.62%)
10 Day Moving Average	$85.1(-0.86%)
20 Day Moving Average	$86.78(-2.78%)
To recent high	-10.3%
To recent low	0.1%
Market Cap	$8.209b

Laboratory Corp. of America Holdings is a clinical laboratory company. The firm engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the following segments: LabCorp Diagnostics and Covance Drug Development. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment provides drug development solutions to companies in the pharmaceutical and biotechnology industries. The company was founded in 1971 and is headquartered in Burlington, NC.

getNextHourMoveProbability failed